Turn Therapeutics Inc. (TTRX)

NASDAQ: TTRX · Real-Time Price · USD
4.770
+0.590 (14.11%)
Oct 23, 2025, 3:55 PM EDT - Market open
14.11%
Market Cap133.67M
Revenue (ttm)n/a
Net Income (ttm)-2.56M
Shares Out 28.02M
EPS (ttm)-0.09
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume153,082
Open4.380
Previous Close4.180
Day's Range4.070 - 4.760
52-Week Range4.070 - 26.500
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About TTRX

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Tu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 4
Stock Exchange NASDAQ
Ticker Symbol TTRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones

Company to host shareholder webinar today, October 22, 2025, at 2:00 PM ET to review execution milestones, pipeline progress, and capital strategy Company to host shareholder webinar today, October 22...

1 day ago - GlobeNewsWire

Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025

LOS ANGELES, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (Nasdaq: TTRX) today announced the launch of a broad communications initiative, featuring a recurring webinar series for shareholders a...

3 days ago - GlobeNewsWire

Turn Therapeutics Appoints Arthur Golden to Board of Directors

Veteran corporate advisor to strengthen governance, oversight, and strategic execution as the Company advances late-stage programs Veteran corporate advisor to strengthen governance, oversight, and st...

9 days ago - GlobeNewsWire

U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown

Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and five SPACs also submitted initial filings. No traditional IPOs are currently scheduled for the week ahead as the government shutdo...

12 days ago - Seeking Alpha

Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics (“Turn” or the “Company”), a clinical-stage biotechnology company developing dermatology, wound care, and anti-infective therapies, today a...

24 days ago - Business Wire